Financial development during COVID-19 pandemic: the role of coronavirus testing and functional labs
Muhammad Khalid Anser,
Muhammad Azhar Khan,
Khalid Zaman (),
Abdelmohsen A. Nassani (),
Sameh E. Askar (),
Muhammad Moinuddin Qazi Abro () and
Ahmad Kabbani
Additional contact information
Muhammad Khalid Anser: Xi’an University of Architecture and Technology
Muhammad Azhar Khan: University of Haripur
Khalid Zaman: University of Haripur
Abdelmohsen A. Nassani: King Saud University
Sameh E. Askar: King Saud University
Muhammad Moinuddin Qazi Abro: King Saud University
Ahmad Kabbani: Aleppo University
Financial Innovation, 2021, vol. 7, issue 1, 1-13
Abstract:
Abstract The outbreak of the SARS-CoV-2 virus in early 2020, known as COVID-19, spread to more than 200 countries and negatively affected the global economic output. Financial activities were primarily depressed, and investors were reluctant to start new financial investments while ongoing projects further declined due to the global lockdown to curb the disease. This study analyzes the money supply reaction to the COVID-19 pandemic using a cross-sectional panel of 115 countries. The study used robust least square regression and innovation accounting techniques to get sound parameter estimates. The results show that COVID-19 infected cases are the main contributing factor that obstructs financial activities and decrease money supply. In contrast, an increasing number of recovered cases and COVID-19 testing capabilities gave investors confidence to increase stock trade across countries. The overall forecast trend shows that COVID-19 infected cases and recovered cases followed the U-shaped trend, while COVID-19 critical cases and reported deaths showed a decreasing trend. Finally, the money supply and testing capacity show a positive trend over a period. The study concludes that financial development can be expanded by increasing the testing capacity and functional labs to identify suspected coronavirus cases globally.
Keywords: Financial development; COVID-19 pandemic; Infected cases; Testing capacity; Robust least square estimator; Innovation accounting matrix (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (6)
Downloads: (external link)
http://link.springer.com/10.1186/s40854-021-00226-4 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:fininn:v:7:y:2021:i:1:d:10.1186_s40854-021-00226-4
Ordering information: This journal article can be ordered from
http://www.springer. ... nomics/journal/40589
DOI: 10.1186/s40854-021-00226-4
Access Statistics for this article
Financial Innovation is currently edited by J. Leon Zhao and Zongyi
More articles in Financial Innovation from Springer, Southwestern University of Finance and Economics
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().